“The compound SR-17018 is the first biased agonist of the mu opioid receptor that does not result in tolerance with Serious use,” claims Stahl, a senior personnel scientist in the Bohn lab. “It is a fascinating attribute for likely use inside the context of chronic, intense suffering.”Click on Fast INQUIRY to receive a quote from our workfo